在增强二次代谢物生物合成的真菌促进剂工程方面的进展
1School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Biotechnology journal
|July 14, 2025
概括
促进器工程通过微调基因转录来增强真菌的二次代谢物 (SM) 生产. 本综述涵盖了促进者替换和优化等技术,以提高SM产量.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 菌类学 菌类学是指菌类学.
背景情况:
- 促进器工程对于调节真菌中的基因转录至关重要.
- 它被广泛用于增强二次代谢物 (SM) 生物合成基因集群 (BGCs) 的表达.
- 这一策略在过去二十年中大大提高了SM生产.
研究的目的:
- 为了提供一个全面的概述,在真菌促进剂工程技术的最新进展.
- 讨论这些技术在增强SM生产中的应用.
- 探索该领域的当前挑战和未来前景.
主要方法:
- 关于真菌中促进体工程的最新文献的综述.
- 促进物替代,优化和组合方法的分析.
- 讨论在SM生产和代谢调节中的应用.
主要成果:
- 促进器工程为控制真菌中的基因表达提供了强大的策略.
- 已经成功地应用了各种技术来提高SM产量.
- 在优化BGC表达方面取得了重大进展.
结论:
- 促进器工程是增强真菌二次代谢物生产的关键工具.
- 对新技术和优化策略的持续研究是必不可少的.
- 应对当前的挑战将为真菌中精确的代谢调节铺平道路.
相关概念视频
Bioreactor Controls-III
71
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
71
Production of Antibiotics
285
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
285
Production of Pharmaceuticals
100
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
100


